|1||NCT02666157||Recruiting||Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation||
||3672||All||20 Years and older (Adult, Senior)||NCT02666157||A-BR-104-049||DARING-AF||January 2016||December 2018||December 2018||January 28, 2016||February 17, 2016||
|Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate||
||Industry / Other||
||18113||All||18 Years and older (Adult, Senior)||NCT00262600||1160.26
|November 2005||April 2009||December 7, 2005||November 18, 2014||February 10, 2011||
† Study has passed its completion date and status has not been verified in more than two years.